Board Change

Clinigen Group plc (AIM: CLIN) (‘Clinigen’ or the ‘Company’ or the ‘Group’), the global pharmaceutical Products and Services company, announces that Nick Keher will be stepping down as a Director of the Company with immediate effect, and as Chief Financial Officer following a handover, to pursue other business interests.

Richard Paling, the Group’s Financial Controller since April 2017, will assume the role of interim Chief Financial Officer and an external search for a new, permanent Chief Financial Officer is underway.

Shaun Chilton, Chief Executive Officer of Clinigen, said: “I would like to thank Nick both personally and on behalf of the Clinigen team for his dedicated work for the Company over the past two and a half years. Nick has played a pivotal role in helping us to deliver on our ambitious strategy against the backdrop of the global COVID-19 pandemic and we wish him every success in the future.”

Nick Keher, outgoing Chief Financial Officer, said: “Clinigen is an exceptional company and it has been a pleasure working with the Clinigen Board and the wider Clinigen team. I look forward to watching the Company continue to grow and deliver value to patients, customers and shareholders.”

Contact details

Clinigen Group plc
Shaun Chilton, Chief Executive Officer
Rob Fox, VP Investor Relations and Corporate Development
+44 (0) 1283 495010

Numis Securities Limited - Nominated Adviser & Joint Broker
James Black / Garry Levin / Freddie Barnfield
+44 (0) 20 7260 1000

RBC Capital Markets - Joint Broker 
Marcus Jackson / Elliot Thomas
+44 () 20 7653 4000

Consilium Strategic Communications
Mary-Jane Elliott / Matthew Cole / Matthew Neal
Tel: +44 (0) 20 3709 5700

Notes to Editors

About Clinigen Group

Clinigen Group plc (AIM: CLIN) is a global, specialist pharmaceutical Services and Products company focused on providing ethical access to medicines. Its' mission is to deliver the right medicine to the right patient at the right time. The Group operates from sites in North America, Europe, Africa and the Asia Pacific.

Clinigen has more than 1,000 employees across five continents in 16 countries, with supply and distribution hubs and operational centres of excellence in key long-term growth regions. The Group works with 34 of the top 50 pharmaceutical companies; interacting with over 5,000 hospitals across more than 115 countries.

For more information on Clinigen, please visit